Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban-Reference-Cited by-同舟云学术

Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban

Published:2013-02-04 Issue:4 Volume:41 Page:827-835
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Zhang Donglu,He Kan,Herbst John J.,Kolb Janet,Shou Wilson,Wang Lifei,Balimane Praveen V.,Han Yong-Hae,Gan Jinping,Frost Charles E.,Humphreys W. Griffith

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference47 articles.

1. Role Reversal for Anticancer Agents

2. P-gp Inhibition Potential in Cell-Based Models: Which “Calculation” Method is the Most Accurate?

3. Apixaban in Patients with Atrial Fibrillation

4. Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid Solubility

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

2. Clinical Implications of Co‐administering Apixaban with Key Interacting Medications;Clinical Pharmacology in Drug Development;2024-07-24

3. Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations;Clinical and Translational Science;2024-05

4. Clinical Analysis and <i>in Vitro</i> Correlation of BCRP-Mediated Drug–Drug Interaction in the Gastrointestinal Tract;Biological and Pharmaceutical Bulletin;2024-04-01

5. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05